BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 15768032)

  • 1. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts.
    Young CS; Masckauchan TN; Kitajewski J
    Differentiation; 2003 Oct; 71(8):477-85. PubMed ID: 14641328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
    von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
    Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein.
    Lee SK; Park MW; Yang EG; Yu J; Jeong S
    Biochem Biophys Res Commun; 2005 Feb; 327(1):294-9. PubMed ID: 15629461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
    Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
    Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N; Spiegelman VS
    Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M; Grandage VL; Linch DC; Khwaja A
    Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO; Barish GD; Klymkowsky MW; Varmus HE
    Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
    Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
    Mi K; Johnson GV
    J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.